Guideline for the Measurement, Analysis and Reporting of Medication Adherence during the Run-in phase of clinical trials (MARMAR)

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

Iaith wreiddiol	Saesneg
Cyfnodolyn	Trials
Dyddiad ar-lein cynnar	16 Ebr 2026
Dynodwyr Gwrthrych Digidol (DOIs)	https://doi.org/10.1186/s13063-026-09717-0
Statws	E-gyhoeddi cyn argraffu - 16 Ebr 2026

Mynediad at Ddogfen

MARMAR manuscript Accepted versionLlawysgrif awdur wedi’i dderbyn, 565 KBTrwydded: CC BY-NC-ND

@article{8e2d8bcafa4a49a58bf888b19bcfa2da,

title = "Guideline for the Measurement, Analysis and Reporting of Medication Adherence during the Run-in phase of clinical trials (MARMAR)",

author = "Non Davies and Bernard Vrijens and Wright, \{Daniel F B\} and Dyfrig Hughes",

year = "2026",

month = apr,

day = "16",

doi = "10.1186/s13063-026-09717-0",

language = "English",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central",

}

TY - JOUR

T1 - Guideline for the Measurement, Analysis and Reporting of Medication Adherence during the Run-in phase of clinical trials (MARMAR)

AU - Davies, Non

AU - Vrijens, Bernard

AU - Wright, Daniel F B

AU - Hughes, Dyfrig

PY - 2026/4/16

Y1 - 2026/4/16

U2 - 10.1186/s13063-026-09717-0

DO - 10.1186/s13063-026-09717-0

M3 - Article

SN - 1745-6215

JO - Trials

JF - Trials

ER -